Mode
Text Size
Log in / Sign up
N/A Completed N=6,139

Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit

Source: ClinicalTrials.gov NCT01332357 ↗
Enrolled (actual)
6,139
Serious AEs
—
Results posted
Oct 2011
Primary outcomePrimary: Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event — 915 participants — p=<0.0001

Summary

The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event
915 <0.0001 sig

Eligibility Criteria

Inclusion Criteria

  • Subjects with asthma as determined by ICD-9 codes and asthma drug use
  • at least 12 years of age
  • discharged from an initial Emergency Department visit within 12 months

Exclusion Criteria

  • Subjects with COPD or treatment for COPD
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01332357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search